// App-Quantinova.ai

PO0289 : Patient Preferences Study for Treatments of Anemia in CKD Patients Not on Dialysis (NDD)

Researchers

Presenter

  • Alexandre Ana filipa

Principal Investigators

  • Morga Antonia

  • Thomas Caitlin

  • Krucien Nicolas

  • Tervonen Tommi

  • Jiletcovici Alina

  • Marsh KevinPatrick

Medical Centers

  • Astellas Pharma Europe, Leiden, Netherlands

  • Astellas Pharma Europe Ltd, Chertsey, UK

  • Evidera, Inc., London, United Kingdom

  • Astellas Pharma, Inc., Northbrook, IL, United States

Locations

  • Netherlands

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Anemia

Biomarkers

  • 3β-hydroxysterol Δ24-reductase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved